rs11195951
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_203379.2(ACSL5):c.432+1412A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.2 in 152,136 control chromosomes in the GnomAD database, including 3,670 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.20 ( 3668 hom., cov: 31)
Exomes 𝑓: 0.35 ( 2 hom. )
Consequence
ACSL5
NM_203379.2 intron
NM_203379.2 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.296
Publications
2 publications found
Genes affected
ACSL5 (HGNC:16526): (acyl-CoA synthetase long chain family member 5) The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme is highly expressed in uterus and spleen, and in trace amounts in normal brain, but has markedly increased levels in malignant gliomas. This gene functions in mediating fatty acid-induced glioma cell growth. Three transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
ACSL5 Gene-Disease associations (from GenCC):
- diarrhea 13Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.255 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ACSL5 | NM_203379.2 | c.432+1412A>T | intron_variant | Intron 5 of 20 | ENST00000354655.9 | NP_976313.1 | ||
| ACSL5 | NM_016234.4 | c.600+1412A>T | intron_variant | Intron 5 of 20 | NP_057318.2 | |||
| ACSL5 | NM_001387037.1 | c.600+1412A>T | intron_variant | Intron 5 of 19 | NP_001373966.1 | |||
| ACSL5 | NM_203380.2 | c.432+1412A>T | intron_variant | Intron 5 of 20 | NP_976314.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ACSL5 | ENST00000354655.9 | c.432+1412A>T | intron_variant | Intron 5 of 20 | 2 | NM_203379.2 | ENSP00000346680.4 |
Frequencies
GnomAD3 genomes AF: 0.201 AC: 30479AN: 151998Hom.: 3668 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
30479
AN:
151998
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.350 AC: 7AN: 20Hom.: 2 Cov.: 0 AF XY: 0.389 AC XY: 7AN XY: 18 show subpopulations
GnomAD4 exome
AF:
AC:
7
AN:
20
Hom.:
Cov.:
0
AF XY:
AC XY:
7
AN XY:
18
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
AC:
2
AN:
2
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
AC:
5
AN:
18
Other (OTH)
AC:
0
AN:
0
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.200 AC: 30486AN: 152116Hom.: 3668 Cov.: 31 AF XY: 0.203 AC XY: 15108AN XY: 74348 show subpopulations
GnomAD4 genome
AF:
AC:
30486
AN:
152116
Hom.:
Cov.:
31
AF XY:
AC XY:
15108
AN XY:
74348
show subpopulations
African (AFR)
AF:
AC:
2462
AN:
41532
American (AMR)
AF:
AC:
3021
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
1171
AN:
3470
East Asian (EAS)
AF:
AC:
1119
AN:
5174
South Asian (SAS)
AF:
AC:
1106
AN:
4808
European-Finnish (FIN)
AF:
AC:
3321
AN:
10572
Middle Eastern (MID)
AF:
AC:
69
AN:
292
European-Non Finnish (NFE)
AF:
AC:
17562
AN:
67970
Other (OTH)
AF:
AC:
481
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1160
2320
3481
4641
5801
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
344
688
1032
1376
1720
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
734
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.